XMTRXometry, Inc.

Price: $92.00 | Today's Change: -3.65%

---

What Happened

Xometry, Inc. filed an 8-K with the SEC on November 3, 2026 (Items 2.02 and 9.01), disclosing its Q2 FY2026 financial results. Revenue from contracts with customers reached $313.5 million for the quarter, while the company reported an operating loss of $25.7 million and a net loss of $61.4 million. On a full-year FY2024 basis, the company reported basic and diluted earnings per share of -$1.68, underscoring a sustained period of unprofitability as the business scales.

---

Why It Matters

For investors, the headline revenue figure of $313.5 million demonstrates that Xometry continues to grow its marketplace at meaningful scale. However, the operating loss of $25.7 million and net loss of $61.4 million in Q2 FY2026 confirm that the path to profitability remains a work in progress. The stock's decline of 3.65% on the day of reporting suggests the market may be focused on the magnitude of the losses rather than the top-line growth. Investors will be watching closely whether operating leverage is improving — that is, whether losses are shrinking as a proportion of revenue — since that ratio is the clearest signal of when Xometry's growth model might inflect toward breakeven.

---

Analysis

The Q2 FY2026 results present a familiar tension for Xometry: a growing, scaled revenue base that has not yet translated into operating profitability. The $313.5 million in quarterly revenue is a material figure for an industrial marketplace, and it speaks to continued adoption of Xometry's platform among buyers and suppliers. Yet the operating loss of $25.7 million points to ongoing investment in sales, technology, and supplier network development that is still outpacing margin gains.

The FY2024 EPS figures of -$1.68 (basic and diluted) serve as useful context: they highlight that losses have been a consistent feature of this growth story, not a new development. What investors and analysts will want to dissect from this filing is the trajectory — specifically whether Q2 FY2026's operating loss represents an improvement relative to prior periods, a data point not directly provided in the structured XBRL facts available here.

This report follows StockWatch's existing initiating coverage on Xometry. The key question this filing raises for ongoing monitoring is whether the company's cost structure is bending favorably as revenue scales — that inflection point, if and when it arrives, would be a significant milestone for the investment thesis.

What to watch next:

• Trend in operating loss as a percentage of revenue quarter-over-quarter
• Commentary from management on margin expansion timeline
• Any guidance revisions accompanying the Q2 results

---

Disclaimer

This report is a news and informational summary of a publicly filed SEC disclosure. It does not constitute investment advice, a solicitation to buy or sell any security, or an equity research recommendation. No rating or price target is issued or implied herein. Investors should conduct their own due diligence and consult a qualified financial adviser before making investment decisions.

Existing Coverage

StockWatch has full coverage on XMTR, published 2026-09-09. Read our Initiating Coverage →

Source

Filed with the SEC on 2026-11-03. Read the original filing on EDGAR: https://www.sec.gov/Archives/edgar/data/1657573/000119312526444354/xmtr-20261103.htm